Inhibition by components of Glycyrrhiza uralensis of 3CLpro and HCoV-OC43 proliferation
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). 3CLpro is a key enzyme in coronavirus proliferation and a treatment target for COVID-19. In vitro and in silico, compounds 1-3 from Glycyrrhiza uralensis had inhibitor...
Saved in:
Main Authors: | Jang Hoon Kim (Author), Yea-In Park (Author), Mok Hur (Author), Woo Tae Park (Author), Youn-Ho Moon (Author), Yun-Chan Huh (Author), Tae IL Kim (Author), Min Hye Kang (Author), Jong Seong Kang (Author), Chong Woon Cho (Author), Junsoo Park (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inhibition of coronavirus HCoV-OC43 by targeting the eIF4F complex
by: Yongmei Feng, et al.
Published: (2022) -
Antiviral Peptides Delivered by Chitosan-Based Nanoparticles to Neutralize SARS-CoV-2 and HCoV-OC43
by: Avinash Mali, et al.
Published: (2023) -
In vivo pharmacokinetics of Glycyrrhiza uralensis polysaccharides
by: Abudukahaer Wubuli, et al.
Published: (2024) -
The therapeutic promises of Lianhuaqingke in the mice model of coronavirus pneumonia (HCoV-229E and SARS-CoV-2)
by: Mingye Wang, et al.
Published: (2021) -
The effect of ethanol extract of Glycyrrhiza uralensis on the voltage-gated sodium channel subtype 1.4
by: Guangwei Zhu, et al.
Published: (2018)